Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Bioproducts Institute (NBI) is a private, non-profit pharmaceutical company based in Pinetown, South Africa, specializing in the manufacture of human plasma-derived medicinal products (PDMPs). As Africa's only plasma fractionator, NBI produces a range of life-saving therapies including clotting factors, immunoglobulins, and albumin solutions, as well as diagnostic kits and monoclonal antibodies. The company operates a cGMP-compliant facility and serves patients across South and Sub-Saharan Africa, with some diagnostic products distributed globally. NBI's mission is to provide affordable and high-quality protein therapies to manage rare diseases, immune disorders, and bleeding disorders. The organization also offers contract manufacturing and biotech services, leveraging its expertise in protein fractionation and biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Bioproducts.